Literature DB >> 21741803

Substance use and regional gray matter volume in individuals at high risk of psychosis.

James M Stone1, Sagnik Bhattacharyya, Gareth J Barker, Philip K McGuire.   

Abstract

Individuals with an at risk mental state (ARMS) are at greatly increased risk of developing a psychotic illness. Risk of transition to psychosis is associated with regionally reduced cortical gray matter volume. There has been considerable interest in the interaction between psychosis risk and substance use. In this study we investigate the relationship between alcohol, cannabis and nicotine use with gray matter volume in ARMS subjects and healthy volunteers. Twenty seven ARMS subjects and 27 healthy volunteers took part in the study. All subjects underwent volumetric MRI imaging. The relationship between regional gray matter volume and cannabis use, smoking, and alcohol use in controls and ARMS subjects was analysed using voxel-based morphometry. In any region where a significant relationship with drug was present, data were analysed to determine if there was any group difference in this relationship. Alcohol intake was inversely correlated with gray matter volume in cerebellum, cannabis intake was use was inversely correlated with gray matter volume in prefrontal cortex and tobacco intake was inversely correlated with gray matter volume in left temporal cortex. There were no significant interactions by group in any region. There is no evidence to support the hypothesis of increased susceptibility to harmful effects of drugs and alcohol on regional gray matter in ARMS subjects. However, alcohol, tobacco and cannabis at low to moderate intake may be associated with lower gray matter in both ARMS subjects and healthy volunteers-possibly representing low-level cortical damage or change in neural plasticity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21741803     DOI: 10.1016/j.euroneuro.2011.06.004

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.

Authors:  Nikolaos Koutsouleris; Stefan Borgwardt; Eva M Meisenzahl; Ronald Bottlender; Hans-Jürgen Möller; Anita Riecher-Rössler
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

2.  Methamphetamine-induced increases in putamen gray matter associate with inhibitory control.

Authors:  Stephanie M Groman; Angelica M Morales; Buyean Lee; Edythe D London; James David Jentsch
Journal:  Psychopharmacology (Berl)       Date:  2013-06-10       Impact factor: 4.530

Review 3.  Developmental mechanisms in the prodrome to psychosis.

Authors:  Elaine F Walker; Hanan D Trotman; Sandra M Goulding; Carrie W Holtzman; Arthur T Ryan; Allison McDonald; Daniel I Shapiro; Joy L Brasfield
Journal:  Dev Psychopathol       Date:  2013-11

4.  Testing associations between cannabis use and subcortical volumes in two large population-based samples.

Authors:  Nathan A Gillespie; Michael C Neale; Timothy C Bates; Lisa T Eyler; Christine Fennema-Notestine; Jasmin Vassileva; Michael J Lyons; Elizabeth C Prom-Wormley; Katie L McMahon; Paul M Thompson; Greig de Zubicaray; Ian B Hickie; John J McGrath; Lachlan T Strike; Miguel E Rentería; Matthew S Panizzon; Nicholas G Martin; Carol E Franz; William S Kremen; Margaret J Wright
Journal:  Addiction       Date:  2018-04-24       Impact factor: 6.526

5.  Study on the sub-regions volume of hippocampus and amygdala in schizophrenia.

Authors:  Fenglian Zheng; Chuntong Li; Dongsheng Zhang; Dong Cui; Zhipeng Wang; Jianfeng Qiu
Journal:  Quant Imaging Med Surg       Date:  2019-06

6.  Accuracy and reliability of automated gray matter segmentation pathways on real and simulated structural magnetic resonance images of the human brain.

Authors:  Lucas D Eggert; Jens Sommer; Andreas Jansen; Tilo Kircher; Carsten Konrad
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.

Authors:  Musa Basseer Sami; Sagnik Bhattacharyya
Journal:  J Psychopharmacol       Date:  2018-03-29       Impact factor: 4.153

Review 8.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.

Authors:  Albert Batalla; Sagnik Bhattacharyya; Murat Yücel; Paolo Fusar-Poli; Jose Alexandre Crippa; Santiago Nogué; Marta Torrens; Jesús Pujol; Magí Farré; Rocio Martin-Santos
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

Review 9.  The myth of schizophrenia as a progressive brain disease.

Authors:  Robert B Zipursky; Thomas J Reilly; Robin M Murray
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

10.  Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis.

Authors:  Lisa Buchy; Tyrone D Cannon; Alan Anticevic; Kristina Lyngberg; Kristin S Cadenhead; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington
Journal:  BMC Psychiatry       Date:  2015-11-09       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.